Cancer-specific activation of the survivin promoter and its potential use in gene therapy.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 740, doi. 10.1038/sj.cgt.7700752
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2004 AND VI 11 AND IP 11
Results: 8
1
2
Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 713, doi. 10.1038/sj.cgt.7700731
- By:
- Publication type:
- Article
3
Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 707, doi. 10.1038/sj.cgt.7700738
- By:
- Publication type:
- Article
4
Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 699, doi. 10.1038/sj.cgt.7700751
- By:
- Publication type:
- Article
5
Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 748, doi. 10.1038/sj.cgt.7700753
- By:
- Publication type:
- Article
6
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 733, doi. 10.1038/sj.cgt.7700756
- By:
- Publication type:
- Article
7
Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 721, doi. 10.1038/sj.cgt.7700783
- By:
- Publication type:
- Article
8
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 11, p. 757, doi. 10.1038/sj.cgt.7700761
- By:
- Publication type:
- Article